SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001193125-21-004358
Filing Date
2021-01-08
Accepted
2021-01-07 18:08:58
Documents
6
Effectiveness Date
2021-01-08

Document Format Files

Seq Description Document Type Size
1 POS EX d41786dposex.htm POS EX 31283
2 EX-1.1 d41786dex11.htm EX-1.1 189684
3 EX-4.10 d41786dex410.htm EX-4.10 93609
4 EX-4.11 d41786dex411.htm EX-4.11 91638
5 EX-5.1 d41786dex51.htm EX-5.1 15361
6 GRAPHIC g41786dsp5.jpg GRAPHIC 4331
  Complete submission text file 0001193125-21-004358.txt   428777
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-250945 | Film No.: 21515088
SIC: 2834 Pharmaceutical Preparations